Abstract. We describe a patient with severe psoriasis and hepatitis C simultaneously treated with pegylated interferon alpha (peg-IFN α ) plus ribavirin and etanercept, whose skin lesions improved and who reached a sustained virological response. This case suggests that refractory psoriasis can today no longer be considered as a contraindication for combined hepatitis C virus treatment.
Chronic hepatitis C virus hepatitis and psoriasis: No longer a contraindication to interferon use in the era of biological agents? / F. Bartalesi; E. Salomoni; A. Cavallo; G. Corti; N. Pimpinelli; A. Bartoloni; G. Taliani. - In: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. - ISSN 0036-5548. - ELETTRONICO. - (2012), pp. 1-4. [10.3109/00365548.2012.720026]
Chronic hepatitis C virus hepatitis and psoriasis: No longer a contraindication to interferon use in the era of biological agents?
CORTI, GIAMPAOLO;PIMPINELLI, NICOLA;BARTOLONI, ALESSANDRO;TALIANI, GLORIA
2012
Abstract
Abstract. We describe a patient with severe psoriasis and hepatitis C simultaneously treated with pegylated interferon alpha (peg-IFN α ) plus ribavirin and etanercept, whose skin lesions improved and who reached a sustained virological response. This case suggests that refractory psoriasis can today no longer be considered as a contraindication for combined hepatitis C virus treatment.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Scand J Infct Dis 2012.pdf
Accesso chiuso
Tipologia:
Altro
Licenza:
Tutti i diritti riservati
Dimensione
89.04 kB
Formato
Adobe PDF
|
89.04 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
